PGR and invasive ductal breast carcinoma: Due to the favorable clinicopathological features of patient EM5 (12 mm primary invasive ductal carcinoma, wide margins, no positive lymph nodes, histological grade 1, estrogen and progesterone receptor positivity, and HER2 negativity), she received postoperative radiotherapy and no systemic adjuvant therapy.